These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Manganism and idiopathic parkinsonism: similarities and differences. Calne DB; Chu NS; Huang CC; Lu CS; Olanow W Neurology; 1994 Sep; 44(9):1583-6. PubMed ID: 7936278 [TBL] [Abstract][Full Text] [Related]
9. Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage. Sikk K; Taba P Int Rev Neurobiol; 2015; 120():257-71. PubMed ID: 26070761 [TBL] [Abstract][Full Text] [Related]
10. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Wang JD; Huang CC; Hwang YH; Chiang JR; Lin JM; Chen JS Br J Ind Med; 1989 Dec; 46(12):856-9. PubMed ID: 2611159 [TBL] [Abstract][Full Text] [Related]
11. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. Hageman G; van der Hoek J; van Hout M; van der Laan G; Steur EJ; de Bruin W; Herholz K J Neurol; 1999 Mar; 246(3):198-206. PubMed ID: 10323318 [TBL] [Abstract][Full Text] [Related]
12. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. Ghika J; Villemure JG; Fankhauser H; Favre J; Assal G; Ghika-Schmid F J Neurosurg; 1998 Nov; 89(5):713-8. PubMed ID: 9817406 [TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? Kim Y; Kim JM; Kim JW; Yoo CI; Lee CR; Lee JH; Kim HK; Yang SO; Chung HK; Lee DS; Jeon B Mov Disord; 2002 May; 17(3):568-75. PubMed ID: 12112209 [TBL] [Abstract][Full Text] [Related]
15. Manganese induced parkinsonism: a case report. Kim JW; Kim Y; Cheong HK; Ito K J Korean Med Sci; 1998 Aug; 13(4):437-9. PubMed ID: 9741552 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia. Silver M; Factor SA Parkinsonism Relat Disord; 2013 Aug; 19(8):758-60. PubMed ID: 23632325 [TBL] [Abstract][Full Text] [Related]
17. Effect of levodopa treatment for parkinsonism in welders: A double-blind study. Koller WC; Lyons KE; Truly W Neurology; 2004 Mar; 62(5):730-3. PubMed ID: 15007122 [TBL] [Abstract][Full Text] [Related]
18. Manganese as possible ecoetiologic factor in Parkinson's disease. Feldman RG Ann N Y Acad Sci; 1992 May; 648():266-7. PubMed ID: 1637054 [No Abstract] [Full Text] [Related]
19. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa]. Fernández Pardal MM; Gatto E; Micheli F; Casas Parera I; Diaz S Medicina (B Aires); 1991; 51(6):561-7. PubMed ID: 7476112 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease. De Michele G; Mengano A; Filla A; Trombetta L; Campanella G Acta Neurol (Napoli); 1989 Dec; 11(6):408-14. PubMed ID: 2694799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]